Pro-Dex (NASDAQ:PDEX) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Pro-Dex (NASDAQ:PDEX – Get Rating) in a note issued to investors on Wednesday. The firm set a “buy” rating on the medical instruments supplier’s stock.

Pro-Dex Trading Up 0.8 %

Shares of NASDAQ:PDEX opened at $18.70 on Wednesday. The firm has a market cap of $66.39 million, a price-to-earnings ratio of 14.72 and a beta of 0.99. Pro-Dex has a 12 month low of $14.47 and a 12 month high of $21.43. The company’s fifty day simple moving average is $16.49 and its 200 day simple moving average is $16.63. The company has a quick ratio of 1.58, a current ratio of 3.07 and a debt-to-equity ratio of 0.36.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of PDEX. Tower Research Capital LLC TRC lifted its stake in Pro-Dex by 345.6% in the 3rd quarter. Tower Research Capital LLC TRC now owns 2,687 shares of the medical instruments supplier’s stock valued at $48,000 after acquiring an additional 2,084 shares in the last quarter. UBS Group AG grew its holdings in shares of Pro-Dex by 421.5% in the 1st quarter. UBS Group AG now owns 5,867 shares of the medical instruments supplier’s stock valued at $96,000 after acquiring an additional 4,742 shares in the last quarter. Renaissance Technologies LLC acquired a new position in shares of Pro-Dex during the 2nd quarter worth approximately $168,000. State Street Corp grew its stake in shares of Pro-Dex by 5.8% in the first quarter. State Street Corp now owns 11,923 shares of the medical instruments supplier’s stock valued at $197,000 after buying an additional 650 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its holdings in Pro-Dex by 59.2% during the first quarter. JPMorgan Chase & Co. now owns 20,863 shares of the medical instruments supplier’s stock worth $345,000 after buying an additional 7,762 shares during the last quarter. 13.49% of the stock is owned by institutional investors and hedge funds.

Pro-Dex Company Profile

(Get Rating)

Pro-Dex, Inc engages in the design, development and manufacture of rotary drive surgical and dental instruments. The firm specializes in medical devices and services, industrial and scientific, dental and component, repairs and other. Its products include finished medical devices, micro air-motors, dental products, plastic injection molding and torque wrenches.